Global Biologics CDMO Market Analysis By Product Type (Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell and Gene Therapies, Blood and Blood Components, Others), By Application (Therapeutic Applications, Diagnostic Applications, Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: April 2025
- Report ID: 146443
- Number of Pages: 392
- Format:
-
keyboard_arrow_up
-
-
- Lonza Group AG Company Profile
- WuXi AppTec
- Samsung Biologics
- Boehringer Ingelheim
- Catalent
- Recipharm
- Fujifilm Diosynth Biotechnologies
- Vetter Pharma
- Rentschler Biopharma
- CordenPharma
- Minakem
- KBI Biopharma
- settingsSettings
Our Clients
- 146443
- April 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
